ArticleCancer drug resistance (Alhambra, Calif.)2019

Components of the human-specific, p53-mediated "kill switch" tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation.

Jonathan NycePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.